1. miR-27b-3p reduces muscle fibrosis during chronic skeletal muscle injury by targeting TGF-βR1/Smad pathway.
- Author
-
Yao, Hang, Qian, Jin, Bian, Xu-ting, Guo, Lin, Tang, Kang-lai, and Tao, Xu
- Subjects
- *
SKELETAL muscle injuries , *GENE therapy , *BIOLOGICAL models , *IN vitro studies , *CARRIER proteins , *PHOSPHORYLATION , *SCIATIC nerve , *RESEARCH funding , *MUSCLE proteins , *MICRORNA , *CELLULAR signal transduction , *REVERSE transcriptase polymerase chain reaction , *FLUORESCENT antibody technique , *IN vivo studies , *FIBROSIS , *GENE expression , *MICE , *ANIMAL experimentation , *GENE expression profiling , *DENERVATION , *CELL differentiation , *STEM cells , *TRANSFORMING growth factors-beta - Abstract
Background: Fibrosis is a significant pathological feature of chronic skeletal muscle injury, profoundly affecting muscle regeneration. Fibro-adipogenic progenitors (FAPs) have the ability to differentiate into myofibroblasts, acting as a primary source of extracellular matrix (ECM). the process by which FAPs differentiate into myofibroblasts during chronic skeletal muscle injury remains inadequately explored. Method: mouse model with sciatic nerve denervated was constructed and miRNA expression profiles between the mouse model and uninjured mouse were analyzed. qRT/PCR and immunofluorescence elucidated the effect of miR-27b-3p on fibrosis in vivo and in vitro. Dual-luciferase reporter identified the target gene of miR-27b-3p, and finally knocked down or overexpressed the target gene and phosphorylation inhibition of Smad verified the influence of downstream molecules on the abundance of miR-27b-3p and fibrogenic differentiation of FAPs. Result: FAPs derived from a mouse model with sciatic nerves denervated exhibited a progressively worsening fibrotic phenotype over time. Introducing agomiR-27b-3p effectively suppressed fibrosis both in vitro and in vivo. MiR-27b-3p targeted Transforming Growth Factor Beta Receptor 1 (TGF-βR1) and the abundance of miR-27b-3p was negatively regulated by TGF-βR1/Smad. Conclusion: miR-27b-3p targeting the TGF-βR1/Smad pathway is a novel mechanism for regulating fibrogenic differentiation of FAPs. Increasing abundance of miR-27b-3p, suppressing expression of TGF-βR1 and inhibiting phosphorylation of smad3 presented potential strategies for treating fibrosis in chronic skeletal muscle injury. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF